UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000043141
Receipt No. R000049213
Scientific Title Clinical evaluation of combined minimally invasive glaucoma surgery and cataract surgery using toric intraocular lens
Date of disclosure of the study information 2021/02/01
Last modified on 2021/01/27 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinical evaluation of combined minimally invasive glaucoma surgery and cataract surgery using toric intraocular lens
Acronym MIGS using toric intraocular lens
Scientific Title Clinical evaluation of combined minimally invasive glaucoma surgery and cataract surgery using toric intraocular lens
Scientific Title:Acronym MIGS using toric intraocular lens
Region
Japan

Condition
Condition Glaucoma
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To compare the refractive status between eyes implanted with toric and non-toric intraocular lenses (IOLs) during combined cataract and microhook ab interno trabeculotomy, a minimally invasive glaucoma surgery (MIGS).
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The primary outcomes were the uncorrected visual acuity (UCVA) and refractive cylinder at 3 months postoperatively.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 toric IOL
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients who had open-angle glaucoma, cataract, and pre-existing regular corneal astigmatism exceeding 1.5 diopters, and underwent combined micro LOT and phacoemulsification were recruited retrospectively.
Key exclusion criteria Eyes were included that had no history of a previous intraocular surgery, no central visual field defect due to glaucoma, no complications during combined micro LOT and cataract surgery, and no postoperative interventions.
Target sample size 30

Research contact person
Name of lead principal investigator
1st name YASUYUKI
Middle name
Last name TAKAI
Organization Shimane University Faculty of Medicine
Division name Department of Ophthalmology
Zip code 6938501
Address Enya89-1, Izumo, Japan
TEL 0853-20-2284
Email takai611@med.shimane-u.ac.jp

Public contact
Name of contact person
1st name YASUYUKI
Middle name
Last name TAKAI
Organization Shimane University Faculty of Medicine
Division name Department of Ophthalmology
Zip code 6938501
Address Enya89-1, Izumo, Japan
TEL 0853-20-2284
Homepage URL
Email takai611@med.shimane-u.ac.jp

Sponsor
Institute Shimane University
Institute
Department

Funding Source
Organization Alcon Japan Ltd. (Tokyo, Japan)
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization IRB of Shimane University Hospital
Address Enya 89-1, Izumo, Japan
Tel 0853-20-2259
Email kenkyu@med.shimane-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 02 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 30
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2018 Year 09 Month 28 Day
Date of IRB
2018 Year 10 Month 03 Day
Anticipated trial start date
2018 Year 10 Month 05 Day
Last follow-up date
2021 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 01 Month 27 Day
Last modified on
2021 Year 01 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049213